Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study
Por um escritor misterioso
Descrição
Frontiers The effects of combination-therapy of tocilizumab and
Two Years into the COVID-19 Pandemic: Lessons Learned
Drug repurposing approach to fight COVID-19
Full article: Therapeutic safety and efficacy of triple
Frontiers The Efficacy and Safety of Janus Kinase Inhibitors for
Post-COVID-19 interstitial lung disease presenting with profound
IJMS, Free Full-Text
Tocilizumab in Hospitalized Patients with Severe Covid-19
Baricitinib Versus Tocilizumab for the Treatment of Moderate to
Cureus Tocilizumab and Baricitinib for Recovery From Acute
Frontiers Immunotherapy of COVID-19: Inside and Beyond IL-6
Tocilizumab in patients hospitalised with COVID-19 pneumonia
Frontiers Efficacy and safety of tocilizumab and baricitinib
Full article: Therapeutic and anti-inflammatory effects of
de
por adulto (o preço varia de acordo com o tamanho do grupo)
